Arrowhead has not initiated research coverage on Episurf Medical AB yet.

About
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating...
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm.
  • 20
    Apr
    17
    News Release
    Notice of Annual General Meeting of Episurf Medical AB (publ)
  • 10
    Apr
    17
    News Release
    Changes in Episurf Medical AB’s management group
  • 6
    Apr
    17
    News Release
    Episurf Medical obtains further granted patent in Australia
  • 3
    Apr
    17
    News Release
    Episurf Medical’s 50th Episealer® implant in Germany demonstrates rapid clinical adoption
  • 31
    Mar
    17
    News Release
    Episurf: Change in number of shares and votes in Episurf Medical AB
  • 16
    Mar
    17
    News Release
    Outcome of Episurf Medical’s rights issue
  • 6
    Mar
    17
    News Release
    Episurf Medical AB Investor Presentation from Aktiedagen Stockholm
  • 2
    Mar
    17
    News Release
    Episurf Medical AB to present at Aktiedagen, held in Stockholm on March 6
  • 23
    Feb
    17
    News Release
    Episurf Medical AB (publ) publishes prospectus; Episurf’s former CEO’s incentive programmes terminated
  • 20
    Feb
    17
    News Release
    Summary From Extraordinary General Meeting of Episurf Medical
  • 20
    Feb
    17
    News Release
    Episurf Medical AB Year-end Report 2016
  • 17
    Feb
    17
    News Release
    Episurf Medical’s 3D-based damage assessment tool: positive development in US patenting
  • 17
    Feb
    17
    Company Presentation
    Episurf Presentation: Addressing a global health problem - ProHearings, Stockholm
  • 15
    Feb
    17
    News Release
    Clinical Marketing Manager is joining Episurf Medical
  • 14
    Feb
    17
    News Release
    Episurf Medical obtains its first granted patents in China
  • 9
    Feb
    17
    News Release
    Episurf Medical AB to present at ProHearings, held in Stockholm on February 17
  • 8
    Feb
    17
    News Release
    Episurf Medical to exhibit at the AAOS 2017 in San Diego, California
  • 23
    Jan
    17
    Company Presentation
    Episurf Medical AB Investor Presentation
  • 19
    Jan
    17
    News Release
    Episurf Medical AB to present at Aktiekvällen, held in Stockholm on January 23
  • 18
    Jan
    17
    News Release
    Episurf Medical AB is expanding its Clinical Advisory Board
  • 5
    Jan
    17
    News Release
    Episurf Medical’s CEO Rosemary Cunningham Thomas steps down - search for new CEO initiated
  • 1
    Dec
    16
    News Release
    Episurf Medical’s 50th Episealer® Femoral Twin implant demonstrates rapid clinical adoption